{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:00:16Z","timestamp":1775916016409,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109793","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:13:12Z","timestamp":1774545192000},"page":"109793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel benzimidazole-based thioamide derivatives as potential anticancer agents: synthesis, biological evaluation, and in silico studies"],"prefix":"10.1016","volume":"175","author":[{"given":"Mahadevi Vitthal","family":"Kendre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin S.","family":"Bhusari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin S.","family":"Wakte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109793_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.109793_bb0010","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.109793_bb0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.bioorg.2026.109793_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.109793_bb0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.109793_bb0030","first-page":"1","article-title":"Benzimidazoles in medicinal chemistry","volume":"115","author":"Grimmett","year":"2015","journal-title":"Adv. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/cr020033s","article-title":"The combinatorial synthesis of bicyclic privileged structures","volume":"103","author":"Horton","year":"2003","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.109793_bb0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00044-010-9533-9","article-title":"Benzimidazole: a medicinally important heterocyclic moiety","volume":"21","author":"Narasimhan","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109793_bb0045","first-page":"223","article-title":"Biological activities of benzimidazole derivatives","volume":"2","author":"Singh","year":"2011","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.bioorg.2026.109793_bb0050","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejmech.2016.12.010","article-title":"Benzimidazole derivatives as anticancer agents","volume":"126","author":"Akhtar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0055","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.ejmech.2010.03.022","article-title":"Synthesis and anticancer activity of novel benzimidazole derivatives","volume":"45","author":"Refaat","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0060","first-page":"188","article-title":"Design, synthesis and anticancer activity of benzimidazole derivatives","volume":"18","author":"Abdel-Rahman","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0065","first-page":"247","article-title":"Biological evaluation of benzimidazole derivatives","volume":"22","author":"Al-Soud","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2026.109793_bb0070","first-page":"1746","article-title":"Thioamides in medicinal chemistry","volume":"18","author":"Schmitt","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0075","series-title":"An Introduction to Organosulfur Chemistry","author":"Cremlyn","year":"1996"},{"key":"10.1016\/j.bioorg.2026.109793_bb0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2014.03.047","article-title":"Thioamide derivatives as anticancer agents","volume":"78","author":"Keri","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0085","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.2174\/092986709788186156","article-title":"Thioamide-containing bioactive molecules","volume":"16","author":"Mugnaini","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0090","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0709662105","article-title":"The T790M mutation in EGFR kinase causes drug resistance","volume":"105","author":"Yun","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.109793_bb0095","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.109793_bb0100","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/onc.2008.109","article-title":"BIBW2992 (Afatinib) and Neratinib as irreversible EGFR inhibitors","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109793_bb0105","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202503545","article-title":"Synthesis, characterization, and anticancer activity of Difluoromethoxy-substituted benzo[d]imidazole derivatives: experimental and computational studies","volume":"10","author":"Kendre","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.109793_bb0115","series-title":"Advanced Organic Chemistry, Part B: Reactions and Synthesis","author":"Carey","year":"2007"},{"key":"10.1016\/j.bioorg.2026.109793_bb0120","series-title":"March\u2019s Advanced Organic Chemistry: Reactions, Mechanisms, and Structure","author":"Smith","year":"2001"},{"key":"10.1016\/j.bioorg.2026.109793_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0135","volume":"163","author":"Gulec","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0140","author":"Hoti","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109793_bb0145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/D4MD00617H","article-title":"Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity","volume":"16","author":"Buza","year":"2025","journal-title":"RSC Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:23:59Z","timestamp":1775913839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":29,"alternative-id":["S0045206826003299"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109793","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel benzimidazole-based thioamide derivatives as potential anticancer agents: synthesis, biological evaluation, and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109793"}}